|
?:authorAffiliation
|
-
[\'Whitehead Institute for Biomedical Research, Cambridge, MA, USA.\', \'Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.\', \'Department of Microbiology, Harvard Medical School, Boston, MA, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston University, Boston, MA, USA.\', \'Department of Nutritional Sciences & Toxicology, University of California, Berkley, CA, 94720, USA.\', \'Innovative Genomics Institute, University of California, Berkeley, CA, 94720, USA.\', \'Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Department of Electrical Engineering & Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.\', \'Whitehead Institute for Biomedical Research, Cambridge, MA, USA. silvi_rouskin@hms.harvard.edu.\', \'Department of Microbiology, Harvard Medical School, Boston, MA, USA. silvi_rouskin@hms.harvard.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}